Bioavailability enhancement of a BCS IV compound via an amorphous combination product containing ritonavir.Published in:Journal of Pharmacy & Pharmacology, 2016, v. 68, n. 5, p. 678, doi. 10.1111/jphp.12478By:Miller, Dave A.;Keen, Justin M.;Brough, Chris;Ellenberger, Daniel J.;Cisneros, Marshall;Williams, Robert O.;McGinity, James W.Publication type:Article